Day: June 20, 2024

Lithium Argentina Reports 2024 Annual General and Special Meeting Results

VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) (“Lithium Argentina” or the “Company”) is pleased to announce the results from its annual general and special meeting held on June 20, 2024 (the “Meeting”). At the Meeting, the eight director nominees listed in the Company’s management information circular dated May 10, 2024 (the “Circular”) were also re-elected as directors to serve until the close of the next annual meeting of shareholders. The detailed results of the vote are set out below: Director Nominees Votes For Votes Withheld John Kanellitsas 57,418,374 (95.19%) 2,901,604 (4.81%) Sam Pigott 59,108,709 (97.99%) 1,211,269 (2.01%) George Ireland 53,677,512 (88.99%) 6,642,466 (11.01%) Diego Lopez Casanello 59,430,054 (98.52%) 889,924 (1.48%) Robert...

Continue reading

Atos – Market Update – 20 June 2024

Press Release Market Update Update on the targeted €800 million short-term interim financing         Final structure agreed for the €450 million short-term interim financing previously committed: €100 million Facilities1 provided by a group of bondholders (fully drawn) €50 million loan from the French State (fully drawn) €225 million additional tranche of facilities backstopped by a group of banks for €125 million and a group of bondholders for €100 million, subject to a waiver from the banks under the €1.5 billion term loan of the Company, to an amendment to the €100 million Facilities previously provided by a group of bondholders and to an agreement in principle on the restructuring terms with the Onepoint Consortium, the Company and the group of banks and bondholders Factoring program reduced to €75 million provided by a group of banks Agreement...

Continue reading

Rakovina Therapeutics Announces Oversubscribed Private Placement and Results from 2024 Annual General Meeting

All dollar amounts reflected in Canadian dollars unless otherwise stated VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce, further to the press release dated May 23, 2024, that it has received subscriptions totalling $1.7 million for its previously announced $1.5 million private placement. The terms of the private placement otherwise remain unchanged. To accommodate additional interest, the Company will upsize the financing to $2.0 Million, subject to TSX-V approval. The Company anticipates a first closing of the private placement on or about June 25, 2024. “Rakovina Therapeutics has benefited greatly from the support...

Continue reading

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for May 2024

Digital Co-Location Business Revenue up 85% Y/Y from May last year Energy Management Revenue up 139% Y/Y from May last year Total Overall Revenue up 19% Y/Y from May last year 20 MW Facility Expansion Progressing Well and Total Capacity Expected to Increase to 129 MW and 41,530 miners MIDLAND, Pa., June 20, 2024 (GLOBE NEWSWIRE) — Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or “the Company”), a digital infrastructure company, announced today its unaudited business and operational update for May 2024. Rahul Mewawalla, CEO and President, commented, “We are pleased with the growth of our digital platforms with 85% year-over-year revenue growth of our digital co-location business and 139% year-over-year revenue growth of our energy management business, compared to May of last year. We have continued to expand our enterprise...

Continue reading

Celestica Amends and Upsizes Credit Facility

TORONTO, June 20, 2024 (GLOBE NEWSWIRE) — Celestica Inc. (TSX: CLS) (NYSE: CLS), a leader in design, manufacturing, hardware platform and supply chain solutions for the world’s most innovative companies, has amended its existing senior secured credit agreement (“Existing Facility”)*, with an upsizing of the total facility to $1.5 billion (“Amended Facility”) to support continuing growth. The Amended Facility consists of the following key changes to the Existing Facility: Revolving loan facility upsized to $750 million (the “Revolver”) Increases the revolving loan commitments from $600 million to $750 million. Maturity date extended from March 2025 to June 2029. New Term A and Term B loans with a total original principal amount of $750 million (the “Term Loans”) Replaces (and terminates) the two existing term loans (aggregate...

Continue reading

AS Silvano Fashion Group of the shareholders – adoption of resolutions of the General Meeting without calling a meeting

The management board of AS Silvano Fashion Group, registry code 10175491, address Tulika tn 17, 10613, Tallinn, Eesti (hereinafter the Company) published on 29 May 2024 pursuant to § 2991 subsections 1, 2 and 3 of the Commercial Code the draft resolutions for the adoption of shareholders’ resolutions without calling a meeting. The list of shareholders entitled to vote was determined as at seven days before the voting term, i.e. on 13 June 2024 at the end of the business day of the settlement system of Nasdaq CSD Estonia. The Company has a total of 3 103 shareholders, who own a total of 36 000 000 shares. The deadline for shareholders to submit their positions was on 20 June 2024,  16:00 (EET).                                  17 shareholders of the Company submitted their votes, whose shares represent in total 22 085 700 votes, that forms...

Continue reading

Chartwell Retirement Residences Announces Acquisition of Ownership Interests in 10 Modern Residences Comprising 3,233 Suites in Quebec and $300 Million Bought Deal Offering of Trust Units

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR DISSEMINATION IN THE UNITED STATES MISSISSAUGA, Ontario, June 20, 2024 (GLOBE NEWSWIRE) — Chartwell Retirement Residences (“Chartwell” or the “Trust”) (TSX: CSH.UN) announces that it has entered into definitive agreements for the strategic acquisition of two seniors housing portfolios in Quebec from separate vendors for an aggregate purchase price of $511 million (the “Portfolio Acquisitions”), consisting of: a 100% ownership interest in a portfolio of five high quality, modern retirement residences with 1,428 suites, located in the Greater Montreal area (the “GMA”), Gatineau, and Sherbrooke (the “GMA Portfolio”)...

Continue reading

Ascot Announces Results of Annual General Meeting Held June 20, 2024

VANCOUVER, British Columbia, June 20, 2024 (GLOBE NEWSWIRE) — Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) reports that at its annual general meeting (the “AGM“) held today, June 20, 2024, Ascot’s Shareholders approved by majority: to elect all seven directors standing for election; to re-appoint PricewaterhouseCoopers LLP as the Company’s auditor; and the philosophy and design of the Company’s executive compensation. Detailed results of the votes held by ballot at the AGM are set out below: Nominee Total Votes Cast For  Votes Withheld  % For  % Withheld  Stephen Altmann 177,145,537  753,143  99.58  0.42  William Bennett 168,004,070  9,894,610  94.44  5.56  Indi Gopinathan 177,159,917  738,763  99.58  0.42  José Marún 177,187,368  711,312  99.60  0.40  Andree St-Germain 176,030,550  1,868,130  98.95  1.05  Derek...

Continue reading

Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ:  CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today the publication of a manuscript in Scientific Reports, demonstrating how three key factors can be determinant for efficient TALE base editing. TALE base editors are a recent and important addition to the gene editing landscape. By design, TALE base editors do not create break within DNA strands as does CRISPR/Cas9, or other engineered nucleases, and is a promising therapeutic strategy for genetic diseases. A key aspect to broaden the scope of possible applications is our comprehension of design rules. TALE base editors rely on the deamination of cytidines within double...

Continue reading

Weatherford Announces Second-Quarter 2024 Conference Call

HOUSTON, June 20, 2024 (GLOBE NEWSWIRE) — Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) will host a conference call on Wednesday, July 24, 2024 to discuss the Company’s results for the second quarter ended June 30, 2024. The conference call will begin at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). Prior to the conference call, the Company will issue a press release announcing the results and the associated presentation slides will be uploaded to the investor relations section of the Weatherford website. Listeners can participate in the conference call via a live webcast. Alternatively, the conference call can be accessed by registering in advance (which will provide a PIN for immediate access) or by dialing +1 877-328-5344 (within the U.S.) or +1 412-902-6762 (outside of the U.S.) and asking...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.